AGP
TENX icon

Artia Global Partners’s Tenax Therapeutics TENX Stock Holding History

Artia Global Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Hold
42,080
– – 0.11% 45
2026
Q1 		$673K Hold
42,080
– – 0.13% 45
2025
Q4 		$513K Buy
+42,080
New +$366K 0.07% 53

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Artia Global Partners's TENX Position: Q2 2026 in Review

Artia Global Partners held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 42,080 shares worth $612K. The position accounts for 0.11% of the portfolio, ranked #45.

Artia Global Partners first reported a position in TENX in Q4 2025 and has held it in 3 quarters since. The position peaked at $673K in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Artia Global Partners held 42,080 shares of Tenax Therapeutics worth $612K as of Q2 2026.
  • Artia Global Partners left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up 0.11% of Artia Global Partners's portfolio in Q2 2026, its #45 holding.
  • Artia Global Partners first reported a position in Tenax Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Artia Global Partners's Tenax Therapeutics position peaked at $673K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.